Ian McKellen said it is with "the greatest reluctance" he is taking medical advice to "protect my recovery" and withdraw from the national tour of Player Kings, following his fall from a West End stage.
The veteran stage and screen actor, 85, was portraying John Falstaff in a production of Player Kings at the Noel Coward Theatre in London when he lost his footing in a fight scene and fell from the stage in June.
After the accident, he was taken to hospital to receive treatment and the remainder of two shows were cancelled to allow him to rest, before his understudy stepped in to finish the rest of the run in the West End.
It has now been confirmed the understudy, David Semark, will also step into McKellen's role for the national tour, which begins on Wednesday.
A statement from McKellen said: "Two weeks after my accident onstage, my injuries improve day by day.
"It's with the greatest reluctance that I have accepted the medical advice to protect my full recovery by not working in the meantime.
"I had been so looking forward to bringing Player Kings to theatre-goers in Bristol, Birmingham, Norwich and Newcastle.
"But I can assure them that, with David Semark now playing Falstaff, Robert Icke's production and his acting company remain as dazzling as ever. Go see for yourself!"
A statement from the production added: "Following Ian McKellen's injury during the West End run of Player Kings, his doctors' advice is to take time off from work in order to fully recover.
"As such, he will not be returning to play Sir John Falstaff in the national tour of Players Kings (3-27 July 2024).
"Ian continues to recuperate very well, but he needs the time to rest and ensure a complete recovery. We continue to send him our best wishes.
"As it was for the final West End performances, the role of Falstaff will now be performed by David Semark, Ian’s brilliant understudy, for all tour dates of Player Kings."
Source: Press Association
Disclaimer: The copyright of this article belongs to the original author. Reposting this article is solely for the purpose of information dissemination and does not constitute any investment advice. If there is any infringement, please contact us immediately. We will make corrections or deletions as necessary. Thank you.
